封面
市場調查報告書
商品編碼
1477937

連續血糖監測系統市場預測:~2032 年

Continuous Glucose Monitoring System Market Research Report Forecast till 2032

出版日期: | 出版商: Market Research Future | 英文 152 Pages | 訂單完成後即時交付

價格

在預測期內,連續血糖監測系統市場規模預計將以 11.24% 的複合年增長率成長。

糖尿病盛行率的增加是推動全球連續血糖監測系統市場成長的一個突出因素。 患有糖尿病的人數正以驚人的速度增加,達到流行病的程度。 根據全球糖尿病聯盟 (IDF) 的數據,2021 年全球約有 5.37 億人患有糖尿病,預計到 2030 年這一數字將躍升至 6.43 億。 此外,根據美國糖尿病協會的數據,到 2021 年,將有 3,840 萬美國人(佔總人口的 11.6%)患有糖尿病。 1 型糖尿病影響著約 200 萬美國人,其中包括約 304,000 名兒童和青少年。 隨著糖尿病人口的持續增長,對有效的糖尿病管理解決方案的需求變得更加迫切。 連續血糖監測系統在即時瞭解血糖水平方面發揮著至關重要的作用,使患者和醫療保健專業人員能夠就治療和生活方式的改變做出及時、明智的決定。 連續血糖監測系統提供連續監測、早期異常檢測和個人化見解的能力滿足了不斷增長的糖尿病族群的需求。

區域見解

北美連續血糖監測系統市場預計到 2023 年將達到 30.7 億美元,在預測期內複合年增長率為 10.06%。

在技術進步和該地區糖尿病盛行率上升的推動下,北美的連續血糖監測系統市場正在經歷強勁增長。

由於技術進步、醫療成本增加和糖尿病盛行率增加,歐洲連續血糖監測系統市場佔據第二大市場。

由於患者人數眾多、臨床試驗成本較低以及有利的監管政策,亞太地區連續血糖監測系統市場預計將在 2023 年至 2030 年期間成長最快。 此外,各大公司積極向該地區擴張也推動了該地區的市場成長。

本報告調查了全球連續血糖監測系統市場,提供了市場的定義和概述,分析了影響市場成長的因素和市場機會、市場規模、各個細分市場/地區/主要的趨勢和預測,它總結了細分:國家、競爭環境和主要公司概況。

目錄

第 1 章執行摘要

第二章市場概述

第三章研究方法

第 4 章市場動態

  • 促進因素
    • 糖尿病盛行率不斷上升
    • 提高個人對持續血糖監測和病患教育益處的認識
    • 人口老化加劇
  • 抑制因素
    • 連續血糖監測系統成本高昂
  • 機會
    • 科技與創新的進步

第四章市場因素分析

  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 對全球連續血糖監測系統的影響

第五章全球連續血糖監測系統市場:依產品

  • 摘要
  • 感測器
  • 發射器和接收器

第 6 章全球連續血糖監測系統市場:依應用分類

  • 摘要
  • 糖尿病類型
  • 糖尿病類型
  • 非糖尿病患者
    • 體重減輕
    • 膳食管理
    • 健康與保健

第 7 章全球連續血糖監測系統市場:依最終用戶劃分

  • 摘要
  • 醫院/診所
  • 居家護理
  • 其他

第 8 章依地區劃分的全球連續血糖監測系統市場

  • 世界
  • 北美
  • 歐洲
  • 亞太地區
  • 其他領域

第九章競爭態勢

  • 市佔率分析
  • 競爭對手儀表板
  • 上市公司股票概覽
  • 比較分析:主要公司財務狀況
  • 主要發展與成長策略

第十章公司簡介

  • DEXCOM, INC
  • A. MENARINI DIAGNOSTICS SRL
  • SENSEONICS
  • MEDTRUM TECHNOLOGIES INC.
  • NEMAURA MEDICAL INC
  • ULTRAHUMAN HEALTHCARE PVT LTD
  • MEDTRONIC
  • ONE DROP
  • ABBOTT LABORATORIES, INC
  • SINOCARE
  • NUTRISENSE
  • SUPERSAPIENS
  • SIGNOS INC.
  • LEVELS
  • VERI
  • LUMEN
  • JANUARY.AI

第 11 章資料引用

Product Code: MRFR/HC/18762-CR

Download PDF

Market Overview

Continuous Glucose Monitoring System Market is projected to register a CAGR of 11.24% during the review period.

The rising pervasiveness of diabetes overall stands apart as a conspicuous driver energizing the development of the worldwide continuous glucose monitoring systems market. Diabetes has arrived at plague extents, with a stunning ascent in the quantity of impacted people universally. As per the Global Diabetes Alliance (IDF), in 2021, roughly 537 million individuals overall were living with diabetes, and this number is supposed to take off to 643 million by 2030. Essentially, as per the American Diabetes Affiliation, diabetes impacted 38.4 million Americans, or 11.6% of the populace, in 2021. Type 1 diabetes influences around 2.0 million Americans, including roughly 304,000 youngsters and teenagers. The heightening rate of diabetes is ascribed to different elements, including stationary ways of life, unfortunate dietary propensities, and the maturing populace. As the diabetic populace keeps on developing, the interest for powerful diabetes the board arrangements turn out to be really squeezing. Continuous glucose monitoring systems assume a vital part in giving constant experiences into blood glucose levels, empowering patients and medical care experts to settle on convenient and informed choices in regard to therapy and way of life changes. The capacity of continuous glucose monitoring systems to offer continuous monitoring, early discovery of variances, and customized bits of knowledge lines up with the developing requirements of the extending diabetic populace.

Market Segmentation

Based on product the continuous glucose monitoring system market is divided into sensors and transmitter and receivers.

In terms of application, the market is classified into type 2 diabetes, type 1 diabetes, and non-diabetic patients.

Based on End user, the market has been divided into hospitals & clinics, homecare settings, and others.

Regional Insights

The North America continuous glucose monitoring systems market represented USD 3.07 billion out of 2023 and is projected to develop at a CAGR of 10.06% during the figure time frame. North America is additionally fragmented into the US, and Canada.

The North America continuous glucose monitoring systems market is encountering strong development, driven by mechanical progressions and a rising predominance of diabetes in the region.

Europe continuous glucose monitoring System market represented the second-biggest market share because of innovation progressions, expanding medical care consumption, and expanding pervasiveness of diabetes.

The Asia-Pacific Continuous Glucose Monitoring System market is supposed to be the quickest developing from 2023 to 2030 attributable to high persistent populace, decreased expenses of leading preliminaries, and good administrative arrangements. In addition, central participants working in the Continuous Glucose Monitoring System Market are effectively venturing into this region, further driving the regional market development.

Major Players

Key Companies operating in the Continuous Glucose Monitoring System market are Dexcom, Inc (US), Menarini Diagnostics Srl (Italy), Senseonics (US), Medtrum Technologies Inc. (China), Nemaura Medical Inc (US), Ultrahuman Healthcare Pvt Ltd (India), Medtronic (Ireland), One Drop (US), Abbott Laboratories, Inc. (US), and Sinocare (China).

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 DEFINITION
  • 1.2 SCOPE OF THE STUDY
  • 1.3 RESEARCH OBJECTIVE
  • 1.4 MARKET STRUCTURE

2 RESEARCH METHODOLOGY

  • 2.1 OVERVIEW
  • 2.2 DATA FLOW
    • 2.2.1 DATA MINING PROCESS
  • 2.3 PURCHASED DATABASE
  • 2.4 SECONDARY SOURCES
    • 2.4.1 SECONDARY RESEARCH DATA FLOW:
  • 2.5 PRIMARY RESEARCH:
    • 2.5.1 PRIMARY RESEARCH DATA FLOW:
    • 2.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
    • 2.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
  • 2.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 2.6.1 REVENUE ANALYSIS APPROACH
  • 2.7 DATA FORECASTING
    • 2.7.1 DATA FORECASTING TECHNIQUE
  • 2.8 DATA MODELING
    • 2.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 2.8.2 DATA MODELING:
  • 2.9 TEAMS AND ANALYST CONTRIBUTION

3 MARKET DYNAMICS

  • 3.1 INTRODUCTION
  • 3.2 DRIVERS
    • 3.2.1 INCREASING PREVALENCE OF DIABETES
    • 3.2.2 RISING AWARENESS AMONG INDIVIDUALS ABOUT THE BENEFITS OF CONTINUOUS GLUCOSE MONITORING AND PATIENT EDUCATION
    • 3.2.3 INCREASING GERIATRIC POPULATION
  • 3.3 RESTRAINTS
    • 3.3.1 HIGH COST OF CONTINUOUS GLUCOSE MONITORING SYSTEMS
  • 3.4 OPPORTUNITY
    • 3.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS AND INNOVATION

4 MARKET FACTOR ANALYSIS

  • 4.1 VALUE CHAIN ANALYSIS
    • 4.1.1 R&D
    • 4.1.2 MANUFACTURING
    • 4.1.3 DISTRIBUTION AND SALES
    • 4.1.4 POST-SALES MONITORING
  • 4.2 PORTER'S FIVE FORCES MODEL
    • 4.2.1 THREAT OF NEW ENTRANTS
    • 4.2.2 BARGAINING POWER OF SUPPLIERS
    • 4.2.3 THREAT OF SUBSTITUTES
    • 4.2.4 BARGAINING POWER OF BUYERS
    • 4.2.5 INTENSITY OF RIVALRY
  • 4.3 IMPACT OF COVID-19 ON THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS

MARKET

    • 4.3.1 OVERVIEW

5 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT

  • 5.1 OVERVIEW
  • 5.2 SENSORS
  • 5.3 TRANSMITTER & RECEIVERS

6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION

  • 6.1 OVERVIEW
  • 6.2 TYPE DIABETES
  • 6.3 TYPE DIABETES
  • 6.4 NON-DIABETIC PATIENTS
    • 6.4.1 WEIGHT LOSS
    • 6.4.2 DIET MANAGEMENT
    • 6.4.3 HEALTH & WELLNESS

7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER

  • 7.1 OVERVIEW
  • 7.2 HOSPITALS & CLINICS
  • 7.3 HOMECARE SETTINGS
  • 7.4 OTHERS

8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION

  • 8.1 GLOBAL
  • 8.2 NORTH AMERICA
    • 8.2.1 US
    • 8.2.2 CANADA
  • 8.3 EUROPE
    • 8.3.1 GERMANY
    • 8.3.2 FRANCE
    • 8.3.3 UK
    • 8.3.4 ITALY
    • 8.3.5 SPAIN
    • 8.3.6 REST OF EUROPE
  • 8.4 ASIA-PACIFIC
    • 8.4.1 CHINA
    • 8.4.2 INDIA
    • 8.4.3 JAPAN
    • 8.4.4 SOUTH KOREA
    • 8.4.5 AUSTRALIA
    • 8.4.6 REST OF ASIA-PACIFIC
  • 8.5 REST OF THE WORLD
    • 8.5.1 MIDDLE EAST & AFRICA
    • 8.5.2 LATIN AMERICA

9 COMPETITIVE LANDSCAPE

  • 9.1 INTRODUCTION
  • 9.2 MARKET SHARE ANALYSIS,
  • 9.3 COMPETITOR DASHBOARD
  • 9.4 PUBLIC PLAYERS STOCK SUMMARY
  • 9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 9.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
    • 9.6.2 AGREEMENT
    • 9.6.3 PARTNERSHIP
    • 9.6.4 COLLABORATION

10 COMPANY PROFILES

  • 10.1 DEXCOM, INC
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 FINANCIAL OVERVIEW
    • 10.1.3 PRODUCTS OFFERED
    • 10.1.4 KEY DEVELOPMENTS
    • 10.1.5 SWOT ANALYSIS
    • 10.1.6 KEY STRATEGIES
  • 10.2 A. MENARINI DIAGNOSTICS SRL
    • 10.2.1 COMPANY OVERVIEW
    • 10.2.2 FINANCIAL OVERVIEW
    • 10.2.3 PRODUCTS OFFERED
    • 10.2.4 KEY DEVELOPMENTS
    • 10.2.5 KEY STRATEGIES
  • 10.3 SENSEONICS
    • 10.3.1 COMPANY OVERVIEW
    • 10.3.2 FINANCIAL OVERVIEW
    • 10.3.3 PRODUCTS OFFERED
    • 10.3.4 KEY DEVELOPMENTS
    • 10.3.5 KEY STRATEGIES
  • 10.4 MEDTRUM TECHNOLOGIES INC.
    • 10.4.1 COMPANY OVERVIEW
    • 10.4.2 FINANCIAL OVERVIEW
    • 10.4.3 PRODUCTS OFFERED
    • 10.4.4 KEY DEVELOPMENTS
    • 10.4.5 KEY STRATEGIES
  • 10.5 NEMAURA MEDICAL INC
    • 10.5.1 COMPANY OVERVIEW
    • 10.5.2 FINANCIAL OVERVIEW
    • 10.5.3 PRODUCTS OFFERED
    • 10.5.4 KEY DEVELOPMENTS
    • 10.5.5 SWOT ANALYSIS
    • 10.5.6 KEY STRATEGIES
  • 10.6 ULTRAHUMAN HEALTHCARE PVT LTD
    • 10.6.1 COMPANY OVERVIEW
    • 10.6.2 FINANCIAL OVERVIEW
    • 10.6.3 PRODUCTS OFFERED
    • 10.6.4 KEY DEVELOPMENTS
    • 10.6.5 KEY STRATEGIES
  • 10.7 MEDTRONIC
    • 10.7.1 COMPANY OVERVIEW
    • 10.7.2 FINANCIAL OVERVIEW
    • 10.7.3 PRODUCTS OFFERED
    • 10.7.4 KEY DEVELOPMENTS
    • 10.7.5 SWOT ANALYSIS
    • 10.7.6 KEY STRATEGIES
  • 10.8 ONE DROP
    • 10.8.1 COMPANY OVERVIEW
    • 10.8.2 FINANCIAL OVERVIEW
    • 10.8.3 PRODUCTS OFFERED
    • 10.8.4 KEY DEVELOPMENTS
    • 10.8.5 SWOT ANALYSIS
    • 10.8.6 KEY STRATEGIES
  • 10.9 ABBOTT LABORATORIES, INC
    • 10.9.1 COMPANY OVERVIEW
    • 10.9.2 FINANCIAL OVERVIEW
    • 10.9.3 PRODUCTS OFFERED
    • 10.9.4 KEY DEVELOPMENTS
    • 10.9.5 SWOT ANALYSIS
    • 10.9.6 KEY STRATEGIES
  • 10.10 SINOCARE
    • 10.10.1 COMPANY OVERVIEW
    • 10.10.2 FINANCIAL OVERVIEW
    • 10.10.3 PRODUCTS OFFERED
    • 10.10.4 KEY DEVELOPMENTS
    • 10.10.5 KEY STRATEGIES
  • 10.11 NUTRISENSE
    • 10.11.1 COMPANY OVERVIEW
    • 10.11.2 FINANCIAL OVERVIEW
    • 10.11.3 PRODUCTS OFFERED
    • 10.11.4 KEY DEVELOPMENTS
    • 10.11.5 KEY STRATEGIES
  • 10.12 SUPERSAPIENS
    • 10.12.1 COMPANY OVERVIEW
    • 10.12.2 FINANCIAL OVERVIEW
    • 10.12.3 PRODUCTS OFFERED
    • 10.12.4 KEY DEVELOPMENTS
    • 10.12.5 KEY STRATEGIES
  • 10.13 SIGNOS INC.
    • 10.13.1 COMPANY OVERVIEW
    • 10.13.2 FINANCIAL OVERVIEW
    • 10.13.3 PRODUCTS OFFERED
    • 10.13.4 KEY DEVELOPMENTS
    • 10.13.5 KEY STRATEGIES
  • 10.14 LEVELS
    • 10.14.1 COMPANY OVERVIEW
    • 10.14.2 FINANCIAL OVERVIEW
    • 10.14.3 PRODUCTS OFFERED
    • 10.14.4 KEY DEVELOPMENTS
    • 10.14.5 KEY STRATEGIES
  • 10.15 VERI
    • 10.15.1 COMPANY OVERVIEW
    • 10.15.2 FINANCIAL OVERVIEW
    • 10.15.3 PRODUCTS OFFERED
    • 10.15.4 KEY DEVELOPMENTS
    • 10.15.5 KEY STRATEGIES
  • 10.16 LUMEN
    • 10.16.1 COMPANY OVERVIEW
    • 10.16.2 FINANCIAL OVERVIEW
    • 10.16.3 PRODUCTS OFFERED
    • 10.16.4 KEY DEVELOPMENTS
    • 10.16.5 KEY STRATEGIES
  • 10.17 JANUARY.AI
    • 10.17.1 COMPANY OVERVIEW
    • 10.17.2 FINANCIAL OVERVIEW
    • 10.17.3 PRODUCTS OFFERED
    • 10.17.4 KEY DEVELOPMENTS
    • 10.17.5 KEY STRATEGIES

11 DATA CITATIONS

LIST OF TABLES

  • TABLE 1 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 3 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTER & RECEIVERS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 4 GLOBAL: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 5 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR WEIGHT LOSS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR DIET MANAGEMENT, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET HEALTH & WELLNESS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOMECARE SETTINGS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 15 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 16 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 17 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
  • TABLE 18 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 19 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 20 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 21 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 22 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 23 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 24 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 25 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 26 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 27 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 28 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 29 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 30 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
  • TABLE 31 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 32 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 33 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 34 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 35 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 36 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 37 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 38 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 39 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 40 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 41 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 42 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 43 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 44 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 45 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 46 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 47 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 48 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 49 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 50 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 51 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 52 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 53 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 54 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 55 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 56 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 57 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 58 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019-2032 (USD BILLION)
  • TABLE 59 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019-2032 (USD BILLION)
  • TABLE 60 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 61 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 62 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 63 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 64 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 65 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 66 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 67 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 68 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 69 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 70 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 71 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 72 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 73 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 74 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 75 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 76 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 77 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 78 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 79 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 80 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 81 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 82 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 83 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 84 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 85 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 86 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 87 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 88 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019-2032 (USD BILLION)
  • TABLE 89 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 90 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 91 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 92 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 93 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 94 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 95 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 96 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 97 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
  • TABLE 98 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
  • TABLE 99 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019-2032 (USD BILLION)
  • TABLE 100 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019-2032 (USD BILLION)
  • TABLE 101 PUBLIC PLAYERS STOCK SUMMARY
  • TABLE 102 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • TABLE 103 PRODUCT LAUNCH/PRODUCT APPROVAL
  • TABLE 104 AGREEMENT
  • TABLE 105 PERTNERSHIP
  • TABLE 106 COLLABORATION
  • TABLE 107 DEXCOM, INC: PRODUCT OFFERED
  • TABLE 108 DEXCOM, INC: KEY DEVELOPMENTS
  • TABLE 109 A. MENARINI DIAGNOSTICS SRL: PRODUCT OFFERED
  • TABLE 110 A. MENARINI DIAGNOSTICS SRL: KEY DEVELOPMENTS
  • TABLE 111 SENSEONICS: PRODUCT OFFERED
  • TABLE 112 SENSEONICS: KEY DEVELOPMENTS
  • TABLE 113 MEDTRUM TECHNOLOGIES INC.: PRODUCTS OFFERED
  • TABLE 114 NEMAURA MEDICAL INC.: PRODUCTS OFFERED
  • TABLE 115 NEMAURA MEDICAL INC.: KEY DEVELOPMENTS
  • TABLE 116 ULTRAHUMAN HEALTHCARE PVT LTD.: PRODCUTS OFFERED
  • TABLE 117 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 118 MEDTRONIC: KEY DEVELOPMENTS
  • TABLE 119 ONE DROP: PRODUCTS OFFERED
  • TABLE 120 ABBOTT LABORATORIES, INC.: PRODUCTS OFFERED
  • TABLE 121 ABBOTT LABORATORIES, INC.: KEY DEVELOPMENTS
  • TABLE 122 SINOCARE: PRODUCTS OFFERED
  • TABLE 123 NUTRISENSE: PRODUCTS OFFERED
  • TABLE 124 NEMAURA MEDICAL INC.: PRODUCTS OFFERED
  • TABLE 125 SIGNOS INC.: PRODUCTS OFFERED
  • TABLE 126 LEVELS: PRODUCTS OFFERED
  • TABLE 127 VERI: PRODUCTS OFFERED
  • TABLE 128 LUMEN: PRODUCTS OFFERED
  • TABLE 129 JANUARY.AI: PRODUCTS OFFERED

LIST OF FIGURES

  • FIGURE 1 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: STRUCTURE
  • FIGURE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: GROWTH FACTOR ANALYSIS (2023-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
  • FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
  • FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
  • FIGURE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)
  • FIGURE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY PRODUCT,
  • FIGURE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
  • FIGURE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY APPLICATION,
  • FIGURE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2023 & 2032 (USD MILLION)
  • FIGURE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY END USER,
  • FIGURE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY REGION, 2023 (% SHARE)
  • FIGURE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 15 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
  • FIGURE 16 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 17 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
  • FIGURE 18 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 19 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 20 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY COUNTRY,
  • FIGURE 21 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 22 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY REGION,
  • FIGURE 23 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET PLAYERS: COMPETITIVE ANALSIS,
  • FIGURE 24 COMPETITOR DASHBOARD: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
  • FIGURE 25 DEXCOM, INC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 26 DEXCOM, INC: SWOT ANALYSIS
  • FIGURE 27 SENSEONICS: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 28 NEMAURA MEDICAL INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 29 NEMAURA MEDICAL INC.: SWOT ANALYSIS
  • FIGURE 30 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 31 MEDTRONIC: SWOT ANALYSIS
  • FIGURE 32 ONE DROP: SWOT ANALYSIS
  • FIGURE 33 ABBOTT LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 34 ABBOTT LABORATORIES INC.: SWOT ANALYSIS